Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-29 @ 6:52 PM
Study NCT ID:
NCT06814106
Status:
COMPLETED
Last Update Posted:
2025-02-07
First Post:
2025-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-08
Completion Date Type:
ACTUAL
First Submit Date:
2025-02-03
First Submit QC Date:
None
Study First Post Date:
2025-02-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-03
Last Update Post Date:
2025-02-07
Last Update Post Date Type:
ACTUAL